HighTower Advisors LLC Has $468,000 Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

HighTower Advisors LLC lowered its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 11.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 17,328 shares of the medical instruments supplier’s stock after selling 2,187 shares during the quarter. HighTower Advisors LLC’s holdings in DENTSPLY SIRONA were worth $468,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in XRAY. Louisiana State Employees Retirement System raised its stake in shares of DENTSPLY SIRONA by 377.2% in the second quarter. Louisiana State Employees Retirement System now owns 58,700 shares of the medical instruments supplier’s stock worth $1,462,000 after acquiring an additional 46,400 shares during the last quarter. Retirement Systems of Alabama grew its holdings in shares of DENTSPLY SIRONA by 448.0% during the second quarter. Retirement Systems of Alabama now owns 256,267 shares of the medical instruments supplier’s stock worth $6,384,000 after buying an additional 209,506 shares in the last quarter. LRI Investments LLC boosted its holdings in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the last quarter. Raymond James Trust N.A. increased its position in shares of DENTSPLY SIRONA by 4.9% in the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after acquiring an additional 453 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in shares of DENTSPLY SIRONA by 28.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 2,090,490 shares of the medical instruments supplier’s stock worth $52,074,000 after purchasing an additional 457,333 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 1.2 %

Shares of NASDAQ:XRAY opened at $18.70 on Friday. The business has a fifty day moving average price of $20.72 and a two-hundred day moving average price of $23.90. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The company has a market capitalization of $3.72 billion, a PE ratio of -9.03, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s revenue was up .4% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 earnings per share. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.42%. DENTSPLY SIRONA’s dividend payout ratio is -30.92%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on XRAY shares. Mizuho initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research note on Friday, November 8th. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Eight research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $27.91.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.